Demitria J. Xiradakis

FDA investigator

Appears on 3 documents from 2015 to 2016, mostly at sites in New York. Most often cites sampling and testing of in-process materials and drug products (21 CFR 211.110).

3
Documents on file
5.3
Observations per 483
2015
First seen
2016
Most recent

What they cite most

From 16 observations

Activity by year

2015: 2, 2016: 1

Where

New York 3

Often inspects with

Samina S. Khan

Is Demitria J. Xiradakis coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 Town Total Compounding CenterApr 20, 2016 · Melville, New York
483 Epic Pharmaz LLCJun 4, 2015 · Laurelton, New York
483 Advance Pharmaceutical IncMar 6, 2015 · Holtsville, New York

About this profile

What does Demitria J. Xiradakis inspect?

Demitria J. Xiradakis appears on 3 documents on file covering 3 sites, mostly in New York.

What do they cite most often?

21 CFR 211.110 (sampling and testing of in-process materials and drug products), followed by 21 CFR 211.100(a) and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Demitria J. Xiradakis is dated Apr 20, 2016.